Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data.
Chlebus K, Cybulska B, Dobrowolski P, Romanowska-Kocejko M, Żarczyńska-Buchowiecka M, Gilis-Malinowska N, Stróżyk A, Borowiec-Wolna J, Pajkowski M, Bobrowska B, Rajtar-Salwa R, Kwapiszewska A, Waluś-Miarka M, Chmara M, Gałąska R, Małecki M, Zdrojewski T, Gruchała M. Chlebus K, et al. Among authors: bobrowska b. Cardiol J. 2022;29(1):62-71. doi: 10.5603/CJ.a2022.0003. Epub 2022 Feb 11. Cardiol J. 2022. PMID: 35146730 Free PMC article.
Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function - advanced diagnosis and therapy in heart failure.
Krawczyk-Ożóg A, Rajtar-Salwa R, Gębka A, Bobrowska B, Bartuś S, Dudek D. Krawczyk-Ożóg A, et al. Among authors: bobrowska b. Postepy Kardiol Interwencyjnej. 2017;13(2):173-175. doi: 10.5114/pwki.2017.68051. Epub 2017 May 30. Postepy Kardiol Interwencyjnej. 2017. PMID: 28798791 Free PMC article. No abstract available.
Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund.
Bobrowska B, Krawczyk-Ożóg A, Bartuś S, Rajtar-Salwa R. Bobrowska B, et al. Postepy Kardiol Interwencyjnej. 2022 Jun;18(2):162-166. doi: 10.5114/aic.2022.118533. Epub 2022 Aug 19. Postepy Kardiol Interwencyjnej. 2022. PMID: 36051838 Free PMC article.
Dissections after bioresorbable vascular scaffold implantation in the POLAR ACS Registry.
Zasada W, Dziewierz A, Partyka L, Wegiel M, Bobrowska B, Depukat R, Rakowski T, Dudek D, Bartus S, Rzeszutko L. Zasada W, et al. Among authors: bobrowska b. Postepy Kardiol Interwencyjnej. 2022 Jun;18(2):131-136. doi: 10.5114/aic.2022.118530. Epub 2022 Aug 19. Postepy Kardiol Interwencyjnej. 2022. PMID: 36051830 Free PMC article.
Comparison of demographics, cardiovascular risk factors profile and prevalence of coexistent atherosclerotic vascular disease in patients with severe aortic stenosis stratified according to dichotomized stenosis severity.
Bobrowska B, Zasada W, Dziewierz A, Kruszelnicka O, Surdacki A, Dudek D. Bobrowska B, et al. Postepy Kardiol Interwencyjnej. 2017;13(4):331-334. doi: 10.5114/aic.2017.71616. Epub 2017 Nov 29. Postepy Kardiol Interwencyjnej. 2017. PMID: 29362577 Free PMC article. No abstract available.
27 results